跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

SML3707

Sigma-Aldrich

Prulifloxacin

≥98% (HPLC)

别名:

(±)-7-[4-[(Z)-2,3-Dihydroxy-2-butenyl]-1-piperazinyl]-6-fluoro-1-methyl-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid cyclic carbonate, 6-Fluoro-1-methyl-7-[4-[(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl]-1-piperazinyl]-4-oxo-1H,4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid, NM 441, NM441

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C21H20FN3O6S
CAS号:
123447-62-1
分子量:
461.46
MDL编号:
MFCD00864847
UNSPSC代码:
12352200
NACRES:
NA.77

质量水平

100

方案

≥98% (HPLC)

表单

powder

颜色

white to beige

溶解性

DMSO: 2 mg/mL, clear (Warmed)

储存温度

-10 to -25°C

SMILES字符串

Fc1cc2c(cc1N4CCN(CC4)CC5=C(OC(=O)O5)C)N3C(SC3=C(C2=O)C(=O)O)C

InChI

1S/C21H20FN3O6S/c1-10-16(31-21(29)30-10)9-23-3-5-24(6-4-23)15-8-14-12(7-13(15)22)18(26)17(20(27)28)19-25(14)11(2)32-19/h7-8,11H,3-6,9H2,1-2H3,(H,27,28)

InChI key

PWNMXPDKBYZCOO-UHFFFAOYSA-N

生化/生理作用

Broad spectrum antibiotic that potently inhibits bacterial DNA gyrase and topoisomerase IV
Prulifloxacin is a synthetic fluoroquinolone broad spectrum antibiotic that potently inhibits bacterial DNA gyrase and topoisomerase IV.

象形图

Health hazardExclamation mark
GHS08,GHS07

警示用语：

Warning

危险声明

H315,H362,H373

危险分类

Lact. - Skin Irrit. 2 - STOT RE 2

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000241011
0000241010
0000237188
0000241011
0000241010

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Gabriele Tulone et al.
Antibiotics (Basel, Switzerland), 11(3) (2022-03-26)
Our study aimed to compare the incidence of infective complications after transrectal ultrasound-guided prostate biopsy (TRUSBx) when adopting different antimicrobial prophylaxis regimens. A multi-institutional cohort of 1150 patients who underwent TRUSBx was retrospectively analyzed. Procedures were performed between 2017 and
M Ozaki et al.
Antimicrobial agents and chemotherapy, 35(12), 2496-2499 (1991-12-01)
NM441 is a lipophilic prodrug of a new thiazeto-quinoline carboxylic acid derivative NM394, and when it is administered orally it is readily absorbed and hydrolyzed to its parent compound. After oral administration of NM441 at a dose of 20 mg/kg
Maria Gabriella Matera
Pulmonary pharmacology & therapeutics, 19 Suppl 1, 20-29 (2005-12-20)
Prulifloxacin, the prodrug of ulifloxacin, is a broad-spectrum oral fluoroquinolone antibacterial agent. After absorption, prulifloxacin is metabolized by esterases to ulifloxacin. The drug has a long elimination half-life, allowing once-daily administration. In vitro, ulifloxacin is generally more active than other

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门